Potential therapeutic use of dermaseptin S4 from the frog Phyllomedusa sauvagii and its derivatives against bacterial pathogens in fish
Journal of Applied Microbiology · 2024
DOI: 10.1093/jambio/lxae222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Afef Braik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Analysis and Process Applied on The Environment- APAE (UR17ES32) Higher Institute of Applied Sciences and Technology of Mahdia, Univ…. Hauptthemen laut MEDLINE: Amphibian Proteins, Antimicrobial Cationic Peptides, Vibrio, Anura. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: European Union.
Abstract (Originalsprache)
Aim
Dermaseptins are one of the main families of antimicrobial peptides (AMPs) derived from the skin secretions of Hylidae frogs. Among them, dermaseptin S4 (DS4) is characterized by its broad-spectrum of activity against bacteria, protozoa, and fungi. In this study, the physicochemical properties of the native peptide DS4 (1–28) and two derivatives [DS4 (1–28)a and DS4 (1–26)a] isolated from the skin of the frog Phyllomedusa sauvagii were investigated and their antimicrobial properties against two marine pathogenic bacteria (Vibrio harveyi and Vibrio anguillarum) were examined. Methods and results The results indicate that the peptide DS4 (1–26)a has high-antibacterial activity against the tested strains and low-hemolytic activity (<30% lysis at the highest tested concentration of 100 µg/mL) compared to the other two peptides tested. In addition, all three peptides affect the membrane and cell wall integrity of both pathogenic bacteria, causing leakage of cell contents, with DS4 (1–26)a having the most severe impact. These skills were corroborated by transmission electron microscopy and by the variation of cations in their binding sites due to the effects caused by the AMPs.
Conclusions
These results suggest that DS4 and its derivatives, in particular the truncated and amidated peptide DS4 (1–26)a could be effective in the treatment of infections caused by these marine pathogenic bacteria. Future studies are required to validate the use of DS4 in vivo for the prevention of bacterial diseases in fish.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Unit of Analysis and Process Applied on The Environment- APAE (UR17ES32) Higher Institute of Applied Sciences and Technology of Mahdia, University of Monastir, Monastir 5019, Tunisia.
- Department of Cell Biology and Histology, Faculty of Biology, University of Murcia, Immunobiology for Aquaculture Group, Murcia 30100, Spain.
- Florida International University, Port St. Lucie, FL 34987, USA.
- Laboratory of Biochemistry, Research Unit: UR 12ES08 "Cell Signaling and Pathologies", Faculty of Medicine of Monastir, University of Monastir, Monastir 5019, Tunisia.
Förderung
- European Union
Zitieren
APA
Braik, A., Serna-Duque, J. A., Nefzi, A., Aroui, S., & Esteban, M. Á. (2024). Potential therapeutic use of dermaseptin S4 from the frog Phyllomedusa sauvagii and its derivatives against bacterial pathogens in fish. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae222
Vancouver
Braik A, Serna-Duque JA, Nefzi A, Aroui S, Esteban MÁ. Potential therapeutic use of dermaseptin S4 from the frog Phyllomedusa sauvagii and its derivatives against bacterial pathogens in fish. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae222
BibTeX
@article{Braik2024,
author = {Braik, Afef and Serna-Duque, John Alberto and Nefzi, Adel and Aroui, Sonia and Esteban, María Ángeles},
title = {Potential therapeutic use of dermaseptin S4 from the frog Phyllomedusa sauvagii and its derivatives against bacterial pathogens in fish},
journal = {Journal of Applied Microbiology},
year = {2024},
doi = {10.1093/jambio/lxae222}
}
EUVIMED